422
BOLTACHEVA et al.
diaminobenzene 4. Yield 0.16 g (64%), mp 108–109°C,
tr 24.22 min. IR spectrum, ν, cm–1: 1182 s (CF), 1239 s
(CF), 1282 m (CF), 1604 m (C=N), 1678 s (C=O). H
CN]+ (7), 119 [CH3С6Н4CO]+ (100), 91 [CH3С6Н4]+,
65 [C5H5]+ (11), 51 [HCF2]+ (1). Found, %: С 68.82; H
3.35; N 7.71; F 15.07. С21Н13F3N2O. Calculated, %: С
68.85; H 3.57; N 7.65; F 15.56.
1
NMR spectrum, CDCl3, δ, ppm: 2.45 s (3H, CH3),
[7.30 d (2Н, 3JHH = 8.1 Hz), 7.81 d (2Н, 3JHH = 8.1 Hz)
Ar], [(7.95–8.01 m (2Н), 8.17–8.23 m (1Н), 8.28–8.33
The reaction of oxime 1c with 2,3-
diaminonaphthalene 5 gave a mixture of products 16,
19c, 11c, 9c, 20c (GC–MS data) (Table 4).
m (1Н), quinoxaline ring]. 13C NMR spectrum, CDCl3,
1
δC, ppm: 21.86; 95.74; 120.75 q (CF3, JCF
=
3-Hydroximino-2-(1,1,2,2,3,3,4,4,4-nonafluoro-
butyl)-4-phenyl-3Н-1,5-benzodiazepin-3-one (8d)
was obtained from 0.3 g (0.76 mmol) of oxime 1d and
0.082 g (0.76 mmol) of 1,2-diaminobenzene 4. Column
chromatography gave 0.1 g (28%) of compound 8d
and 0.06 g (23%) of benzimidazole 14d. mp 142–147°C.
IR spectrum, ν, cm–1: 1129 s (CF), 1193 s (CF), 1232
m (CF), 1450 m (C=N), 1572 s (C=N), 3134 br (OH).
1H NMR spectrum, CDCl3, δ, ppm: [7.39–7.46 m
(2Н), 7.48–7.57 m (3Н)] Ph, 7.60–7.77 m (2Н), 7.89 s
276.1 Hz), 129.50, 129.53, 129.93, 130.70, 133.34,
133.13, 140.38, 141.04 q (CCF3, JCF = 36.3 Hz),
2
141.41, 145.75, 149.40, 190.85 (C=O). 19F NMR
spectrum (CDCl3): δF –64.63 ppm. GC-MS (EI, in
C2H5OH, TIC): m/z (Irel, %): 316 [M]+ (6), 301 [M –
CH3]+ (2), 288 [M – CO]+ (1), 247 [M – CF3]+ (1), 197
[M – CH3C6H4CO]+ (1), 128 [M – CF3 – CH3C6H4CO]+
(1), 119 [CH3C6H4CO]+ (100), 91 [CH3C6H4]+ (33), 69
[CF3]+ (3), 65 [C5H5]+ (12), 51 [HCF2]+ (3). Found, %:
С 64.54; H 3.51; N 8.78; F 17.69. С17Н11F3N2O.
Calculated, %: С 64.56; H 3.51; N 8.86; F 18.02.
3
(1Н, ОН), 8.06 d (2Н, JHH = 7.3 Hz). Found, %: С
48.67; H 2.15; N 9.01; F 36.25. С19Н10F9N3O.
Calculated, %: С 48.84; H 2.16; N 8.99; F 36.59.
(4-Phenyl)-{3-(trifluoromethyl)benzo[g]quino-
xalin-2-yl}methanone (9a) was obtained from 0.25 g
(1.0 mmol) of oxime 1a and 0.16 g (1.0 mmol) of 2,3-
diaminonaphthalene 5. Yield 0.2 g (57%), mp 158–
159°C. IR spectrum, ν, cm–1: 1126 s (CF), 1190 s (CF),
1202 m (CF), 1596 m (C=N), 1673 s (C=O). 1H NMR
spectrum, CDCl3, δ, ppm: 7.49–7.57 m (2Н), 7.64–
The reaction of oxime 1e with 2,3-diamino-
naphthalene 5, according to GC–MS data, gave a
complex mixture, the major components being 2-
(1,1,2,2,3,3,4,4-octafluorobutyl)naphthoimidazole 19e
and (4-phenyl)[3-(1,1,2,2,3,3,4,4-octafluorobutyl)benzo-
[g]quinoxalin-2-yl]methanone 9e. 2-(1,1,2,2,3,3,4,4-
Octafluorobutyl)naphthoimidazole (19e) was iso-
lated by preparative column chromatography, mp 215–
217°C, tr 23.31 min. IR spectrum, ν, cm–1: 1143 s (CF),
1170 s (CF), 1274 m (CF), 1476 m (C=N), 3040–2865
br (NH). GC-MS (EI, in CHCl3, TIC): m/z (Irel, %):
368 [M]+ (8), 349 [M – F]+ (1), 317 [M – HCF2]+ (<1),
297 [M – HCF2 – HF]+ (<1), 268 [M – 2CF2]+ (2), 248
[M – 2CF2 – HF]+ (4), 217 [M – HC3F6]+ (30), 197 [M –
HC3F6 – HF]+ (9), 190 [M – HC3F6 – HCN]+ (6), 152
[C11H6N]+ (19), 145 [C10H6F]+ (27), 140 [C10H6N]+ (41),
125 [C10H5]+ (7), 113 [C9H5]+ (26), 69 [CF3]+ (36), 51
[HCF2]+ (100), 39 [HF2]+ (5).
3
7.72 m (3Н), 8.00 d (2Н, JHH 7.6 Hz), 8.11–8.21 m
(2Н), 8.77 s (1Н), 8.9 s (1Н). 13C NMR spectrum,
CDCl3, δс, ppm: 98.1, 120.67 q (CF3, 1JCF = 276.2 Hz),
128.25, 128.50, 128.76, 128.84, 129.19, 130.67, 134.47,
134.73, 135.08, 135.59, 136.03, 136.72, 141.51 q
2
(CCF3, JCF = 36.4 Hz), 148.82, 191.20 (C=O). 19F
NMR spectrum (CDCl3), δF –64.83 ppm. Found, %: С
67.99; H 3.24; N 7.89; F 15.89. С20Н11F3N2O. Cal-
culated, %: С 68.18; H 3.15; N 7.95; F 16.18.
(4-Methylphenyl)-{3-(trifluoromethyl)benzo[g]-
quinoxalin-2-yl}methanone (9b) was obtained from
0.2 g (0.77 mmol) of oxime 1b and 0.12 g (0.77 mmol)
of 2,3-diaminonaphthalene 5. Yield 0.16 g (57%), mp
157.5–158.5оС, tr 31.23 min. IR spectrum, ν, cm–1:
1138 s (CF), 1185 s (CF), 1204 m (CF), 1604 m
The reaction of oxime 1f with 2,3-diamino-
naphthalene 5, according to GC–MS data, gave a
mixture of products 9f, 11f, 19f, 20f, 21f, from which
0.31 g (66%) of 2-(1,1,2,2,3,3,4,4,5,5,6,6,6-trideca-
fluorohexyl)naphthoimidazole (19f) was isolated, mp
148–149оС, tr 22.32 min. IR spectrum, ν, cm–1: 1144 s
(CF), 1202 s (CF), 1238 m (CF), 1479 m (NH), 1588
w (C=N), 3040–2615 br (NH). GC–MS (EI, in
C2H5OH, TIC): m/z (Irel, %): 486 [M]+ (4), 467 [M – F]+
(<1), 367 [M – C2F5]+ (<1), 347 [M – C2F5 – HF]+ (<1),
317 [M – C3F7]+ (2), 298 [M – C3F7 – F]+ (4), 278 [M –
1
(C=N), 1672 s (C=O). H NMR spectrum, CDCl3, δ,
ppm: 2.47 s (3H, CH3), [7.33 d (2H, 3JHH = 8.1 Hz),
7.89 d (2H, 3JHH = 8.1 Hz), С6Н4], [7.70 m (2Н), 8.14
m (2Н), 8.24 m (2Н)], 8.79 s (1Н)], 8.91 s (1Н) quino-
xaline]. 19F NMR spectrum (CDCl3), δF –64.93 ppm.
GC-MS (EI, in C2H5OH, TIC): m/z (Irel, %): 366 [M]+
(7), 351 [M – CH3]+ (1), 338 [M – CO]+ (2), 297 [M –
CF3]+ (1), 247 [M – CH3С6Н4CO]+ (1), 178 [M –
CH3С6Н4CO – CF3]+ (2), 152 [M – CH3С6Н4CO – CF3 –
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 89 No. 3 2019